Global Azithromycin Market Size To Exceed USD 13.30 Billion by 2035| CAGR of 5.35%
Category: HealthcareAccording to a research report published by Spherical Insights & Consulting, The Global Azithromycin Market Size is Expected To Grow from USD 7.50 Billion in 2024 to USD 13.30 Billion by 2035, at a CAGR of 5.35% during the Forecast Period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 120 Market data tables and figures & charts from the report on the "Global Azithromycin Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Respiratory Infections, Skin Infections, Ear & Eye Infections, and STIs), By End-User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Specialty Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/azithromycin-market
The azithromycin market refers to the industry that encompasses the production, distribution, and sale of azithromycin, an antibiotic used for treating bacterial infections. Azithromycin is an antibiotic medicine, used for treating infections like pneumonia, sinusitis, skin infections, Lyme disease, and STIs, available as capsules, tablets, and a liquid on prescription, and can also be given by injection in a hospital. Research and development activities and awareness about bacterial infections and their treatment options are driving the growth of the azithromycin market. The increasing innovation in drug delivery techniques, like sustained release formulation or long-acting injectables, is escalating the market growth opportunities. The growing prevalence of respiratory and other infectious diseases, emphasis on innovative solutions, and increased public awareness are driving the market growth. However, the increasing safety concerns, regulatory complexity, and supply chain disruptions are challenging the market.
The respiratory infection segment dominated the market with a major share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the application, the azithromycin market is divided into respiratory infections, skin infections, ear & eye infections, and STIs. Among these, the respiratory infection segment dominated the market with a major share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The increasing demand for azithromycin for the treatment of respiratory diseases like COPD and asthma is propelling the market demand, as it has short treatment courses and a convenient once-daily dosage.
The hospital pharmacies segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the end-user, the azithromycin market is divided into hospital pharmacies, retail pharmacies, online pharmacies, and specialty clinics. Among these, the hospital pharmacies segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Hospital pharmacies are the preferred distribution channel for compounded drugs. The prevalence of severe infections is driving the need for hospitalization, which is anticipated to propel the market.
North America is expected to hold the majority share of the global azithromycin market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global azithromycin market during the forecast period. The growing prevalence of bacterial infections, along with an increasing need for effective antibiotic treatments, is propelling the azithromycin market. The presence of key pharmaceutical companies and a strong healthcare infrastructure is also responsible for market growth.
Asia Pacific is anticipated to grow at the fastest pace in the global azithromycin market during the forecast period. The increasing patient population suffering from infectious diseases is contributing to driving the market demand. The region’s increasing disposable income levels and developing healthcare sectors are propelling the azithromycin market.
Major vendors in the global azithromycin market are Pfizer, Teva Pharmaceutical Industries Ltd., Lupin, Akorn, Anke Hengyi, Aurobindo Pharma, CSPC Ouyi Pharmaceutical, Gland Pharma, Hainan Hailing Chemipharma Corporation, Hainan Poly Pharm, Sandoz, Wockhardt, Zydus Pharmaceuticals, Alembic Pharmaceuticals Limited, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In July 2024, ZIM Laboratories announced that INFARMED (Portugal), the Portuguese National Authority of Medicines and Health Products, has granted the Marketing Authorisation for one of ZIM’s New Innovative Products (NIP) ” Azithromycin for Oral Suspension 200 mg/5ml ” in Portugal to ZIM’s wholly owned European Subsidiary – SIA ZIM Laboratories.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the azithromycin market based on the below-mentioned segments:
Global Azithromycin Market, By Application
- Respiratory Infections
- Skin Infections
- Ear & Eye Infections
- STIs
Global Azithromycin Market, By End-User
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Specialty Clinics
Global Azithromycin Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?